Chemours
516 hedge funds and large institutions have $3.55B invested in Chemours in 2022 Q2 according to their latest regulatory filings, with 79 funds opening new positions, 119 increasing their positions, 176 reducing their positions, and 40 closing their positions.
98% more first-time investments, than exits
New positions opened: 79 | Existing positions closed: 40
7% more funds holding
Funds holding: 482 → 516 (+34)
4% less capital invested
Capital invested by funds: $3.68B → $3.55B (-$133M)
2.14% less ownership
Funds ownership: 73.32% → 71.18% (-2.1%)
22% less funds holding in top 10
Funds holding in top 10: 9 → 7 (-2)
32% less repeat investments, than reductions
Existing positions increased: 119 | Existing positions reduced: 176
45% less call options, than puts
Call options by funds: $55M | Put options by funds: $99.6M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$64.4M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$36.6M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$25.1M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$20.4M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$20M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Sessa Capital
New York
|
-$147M |
| 2 |
GC
Greenlight Capital
New York
|
-$53M |
| 3 |
Allianz Asset Management
Munich,
Germany
|
-$35.3M |
| 4 |
VNIM
Vaughan Nelson Investment Management
Houston,
Texas
|
-$25.6M |
| 5 |
Millennium Management
New York
|
-$23.4M |
CC Hedge Fund Activity: Q2 2022 in Review
516 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Chemours (CC) for Q2 2022, worth a combined $3.55B — down 3.6% from $3.68B a quarter earlier.
Buyers outnumbered sellers: 79 funds opened new CC positions and 40 closed out — a net gain of 39 holders — while 119 added to existing stakes and 176 trimmed.
The largest buyer was Bank of America, adding an estimated $64.4M. The largest seller was Sessa Capital, cutting an estimated $147M.
- 516 institutional investors held Chemours (CC) as of Q2 2022, up from 482 in Q1 2022.
- Funds reported $3.55B of Chemours stock for Q2 2022, down 3.6% quarter-over-quarter.
- 79 funds opened new Chemours positions in Q2 2022 and 40 closed out, a net change of +39 holders.
- The largest Chemours buyer in Q2 2022 was Bank of America, an estimated $64.4M added.
- The largest Chemours seller in Q2 2022 was Sessa Capital, an estimated $147M sold.
Based on aggregated 13F filings for Q2 2022.